Rep. Cathy McMorris Rodgers (R-WA) (J. Scott Applewhite/AP Images)
August 4, 2023 01:27 PM EDT
People
FDA+

House E&C chair racks up cam­paign con­tri­bu­tions from more than 30 bio­phar­ma com­pa­nies so far in 2023

Zachary Brennan

Senior Editor

Rep. Cathy Mc­Mor­ris Rodgers (R-WA) chairs the most im­por­tant House com­mit­tee, En­er­gy and Com­merce, when it comes to bio­phar­ma in­ter­ests. And her 2024 re­elec­tion cam­paign …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times